An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Drug Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users injecting substances of uncertain source.
Some professionals said the demand for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer laws, potentially leading to penalties, legal action or prison.
Platform Response and Content Removal
Based on TikTok, the service has taken down problematic content and banned related hashtags and query recommendations. The organization stated it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.
Digital Trading Activities
Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, positive reviews and detailed instructions for mixing or injecting at residence.
After moments of joining one group, a vendor shared contact information, where most purchases take place. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.
Product Information and Costs
Within these communities, posts show dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for Telegram said it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering substances they cannot confirm. Although the science behind retatrutide is valid, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has previously seen patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially serious health risks”.
